Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Oct-21 5:04 PM View:  | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 907,766 | -- | -- | 100% 0 to 907.77K | |
| 26-Oct-21 5:04 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 500,000 | $16.00 | $8,000,000.00 | 55% 907.77K to 1.41M | |
| 14-Oct-21 5:00 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 436,649 | -- | -- | 100% 0 to 436.65K | |
| 14-Oct-21 5:00 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Market Purchase | 250,000 | $16.00 | $4,000,000.00 | 57% 436.65K to 686.65K | |
| 22-Jun-21 5:20 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Conversion | 709,224 | -- | -- | 100% 0 to 709.22K | |
| 22-Jun-21 5:20 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Private Purchase Duplicate | 370,000 | $19.00 | $7,030,000.00 | 52% 709.22K to 1.08M | |
| 04-Nov-20 4:05 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Conversion | 1,694,420 | -- | -- | 100% 0 to 1.69M | |
| 04-Nov-20 4:05 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Purchase Duplicate | 250,000 | $24.00 | $6,000,000.00 | 15% 1.69M to 1.94M | |
| 28-Jul-20 8:53 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion | 467,884 | -- | -- | 45% 1.04M to 1.51M | |
| 28-Jul-20 8:53 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase Duplicate | 600,000 | $16.00 | $9,600,000.00 | 40% 1.51M to 2.11M | |
| 16-Mar-20 5:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion | 273,411 | -- | -- | 100% 0 to 273.41K | |
| 16-Mar-20 5:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Purchase | 250,000 | $16.00 | $4,000,000.00 | 91% 273.41K to 523.41K | |
| 04-Apr-18 4:24 PM View: | Q32 Bio Inc. (QTTB) | 02-Apr-18 | Conversion Duplicate | 395,845 | -- | -- | 100% 0 to 395.85K | |
| 04-Apr-18 4:24 PM View: | Q32 Bio Inc. (QTTB) | 02-Apr-18 | Purchase | 250,000 | $16.00 | $4,000,000.00 | 63% 395.85K to 645.85K | |
| 24-Jun-15 4:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Jun-15 | Conversion Duplicate | 364,358 | -- | -- | 100% 0 to 364.36K | |
| 24-Jun-15 4:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Jun-15 | Market Purchase | 200,000 | $14.00 | $2,800,000.00 | 55% 364.36K to 564.36K | (72%) |
| 15-Apr-14 8:24 PM View: | Cerulean Pharma Inc. (DARE) | 15-Apr-14 | Conversion | 464,365 | -- | -- | 100% 0 to 464.37K |